(RZLV) Rezolve AI Ordinary Shares - Ratings and Ratios
Ai Platform, Retail, E-Commerce, Consumer, Dynamic
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 68.3% |
| Value at Risk 5%th | 93.7% |
| Relative Tail Risk | -16.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 13.96 |
| CAGR/Max DD | -0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.543 |
| Beta | 1.826 |
| Beta Downside | 1.300 |
| Drawdowns 3y | |
|---|---|
| Max DD | 91.85% |
| Mean DD | 33.06% |
| Median DD | 4.91% |
Description: RZLV Rezolve AI Ordinary Shares November 14, 2025
Rezolve AI PLC (NASDAQ:RZLV) develops generative-AI tools tailored for retailers, brands, and manufacturers, enabling real-time, personalized consumer engagement across multiple channels and devices. The London-based firm, founded in 2016 and rebranded from Rezolve AI Limited to PLC in March 2025, is classified under the GICS Sub-Industry “Application Software.”
Key industry metrics that shape Rezolve’s growth outlook include: (1) global generative-AI market revenue projected to exceed $50 billion by 2027, with a CAGR of ~38 % (IDC, 2024); (2) e-commerce GMV in Europe rising 12 % YoY in Q2 2025, driven by omnichannel adoption; and (3) SaaS-based AI platforms reporting average ARR retention rates above 95 %, indicating strong customer stickiness. Assuming Rezolve can capture even 0.5 % of the European retail AI spend, incremental revenue could reach $15-$20 million annually, subject to execution risk and competitive pressure from larger cloud providers.
For a deeper, data-driven assessment of Rezolve’s valuation and risk profile, you may find ValueRay’s analytical framework a useful next step.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-195.6m TTM) > 0 and > 6% of Revenue (6% = 762.1k TTM) |
| FCFTA -0.48 (>2.0%) and ΔFCFTA -1.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -559.5% (prev -26.4k%; Δ 25.8kpp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.48 (>3.0%) and CFO -38.1m > Net Income -195.6m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.24 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (233.5m) change vs 12m ago 12.13% (target <= -2.0% for YES) |
| Gross Margin 95.58% (prev 79.70%; Δ 15.88pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 25.43% (prev 0.86%; Δ 24.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -21.93 (EBITDA TTM -125.9m / Interest Expense TTM 5.88m) >= 6 (WARN >= 3) |
Altman Z'' -39.56
| (A) -0.89 = (Total Current Assets 22.6m - Total Current Liabilities 93.6m) / Total Assets 80.1m |
| (B) -3.95 = Retained Earnings (Balance) -316.1m / Total Assets 80.1m |
| warn (B) unusual magnitude: -3.95 — check mapping/units |
| (C) -2.58 = EBIT TTM -129.0m / Avg Total Assets 49.9m |
| (D) -3.35 = Book Value of Equity -316.4m / Total Liabilities 94.4m |
| Total Rating: -39.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 39.73
| 1. Piotroski 1.0pt |
| 2. FCF Yield -3.88% |
| 3. FCF Margin data missing |
| 4. Debt/Equity -2.49 |
| 5. Debt/Ebitda -0.20 |
| 7. RoE 967.6% |
| 8. Rev. Trend 0.39% |
| 9. EPS Trend -37.24% |
What is the price of RZLV shares?
Over the past week, the price has changed by +1.67%, over one month by -31.46%, over three months by -15.28% and over the past year by +43.87%.
Is RZLV a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RZLV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10 | 227.9% |
| Analysts Target Price | 10 | 227.9% |
| ValueRay Target Price | 3 | -2.6% |
RZLV Fundamental Data Overview November 24, 2025
P/S = 182.602
Beta = -0.233
Revenue TTM = 12.7m USD
EBIT TTM = -129.0m USD
EBITDA TTM = -125.9m USD
Long Term Debt = 121.1k USD (from longTermDebt, two quarters ago)
Short Term Debt = 34.8m USD (from shortTermDebt, last quarter)
Debt = 35.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.7m USD (from netDebt column, last quarter)
Enterprise Value = 984.3m USD (958.6m + Debt 35.6m - CCE 9.86m)
Interest Coverage Ratio = -21.93 (Ebit TTM -129.0m / Interest Expense TTM 5.88m)
FCF Yield = -3.88% (FCF TTM -38.2m / Enterprise Value 984.3m)
FCF Margin = -300.9% (FCF TTM -38.2m / Revenue TTM 12.7m)
Net Margin = -1540 % (Net Income TTM -195.6m / Revenue TTM 12.7m)
Gross Margin = 95.58% ((Revenue TTM 12.7m - Cost of Revenue TTM 561.0k) / Revenue TTM)
Gross Margin QoQ = 95.63% (prev 95.63%)
Tobins Q-Ratio = 12.29 (Enterprise Value 984.3m / Total Assets 80.1m)
Interest Expense / Debt = 5.93% (Interest Expense 2.11m / Debt 35.6m)
Taxrate = -0.86% (negative due to tax credits) (247.1k / -28.7m)
NOPAT = -130.1m (EBIT -129.0m * (1 - -0.86%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 0.24 (Total Current Assets 22.6m / Total Current Liabilities 93.6m)
Debt / Equity = -2.49 (negative equity) (Debt 35.6m / totalStockholderEquity, last quarter -14.3m)
Debt / EBITDA = -0.20 (negative EBITDA) (Net Debt 25.7m / EBITDA -125.9m)
Debt / FCF = -0.67 (negative FCF - burning cash) (Net Debt 25.7m / FCF TTM -38.2m)
Total Stockholder Equity = -20.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -244.2% (out of range, set to none)
RoE = 967.6% (negative equity) (Net Income TTM -195.6m / Total Stockholder Equity -20.2m)
RoCE = 642.1% (negative capital employed) (EBIT -129.0m / Capital Employed (Equity -20.2m + L.T.Debt 121.1k))
RoIC = -1634 % (out of range, set to none) (NOPAT -130.1m / Invested Capital 7.97m)
WACC = 12.50% (E(958.6m)/V(994.2m) * Re(12.74%) + D(35.6m)/V(994.2m) * Rd(5.93%) * (1-Tc(-0.01)))
Discount Rate = 12.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 437.8%
Fair Price DCF = unknown (Cash Flow -38.2m)
EPS Correlation: -37.24 | EPS CAGR: -71.83% | SUE: N/A | # QB: 0
Revenue Correlation: 0.39 | Revenue CAGR: 4.82% | SUE: N/A | # QB: 0
EPS current Year (2025-12-31): EPS=-0.22 | Chg30d=-0.022 | Revisions Net=-1 | Growth EPS=+79.0% | Growth Revenue=+21437.2%
EPS next Year (2026-12-31): EPS=-0.06 | Chg30d=+0.015 | Revisions Net=+2 | Growth EPS=+75.3% | Growth Revenue=+143.5%
Additional Sources for RZLV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle